Cilgavimab
Cilgavimab Uses, Dosage, Side Effects, Food Interaction and all others data.
Cilgavimab is under investigation in clinical trial NCT04625725 (Phase III Double-blind, Placebo-controlled Study of AZD7442 for Pre-exposure Prophylaxis of COVID-19 in Adult.).
| Trade Name | Cilgavimab |
| Generic | Cilgavimab |
| Cilgavimab Other Names | Cilgavimab |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | September 19, 2023 at 7:00 am |
Innovators Monograph
You find simplified version here Cilgavimab
